Jacques de Champlain

Jacques de Champlain's AcademicInfluence.com Rankings

Philosophy

#5881

World Rank

#8805

Historical Rank

Logic

#3088

World Rank

#4197

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacques de Champlain's Degrees

Doctorate Medicine McGill University

Why Is Jacques de Champlain Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jacques de Champlain, OC was a scientist, doctor and professor from the Province of Quebec. Jacques de Champlain was a graduate of the Université de Montréal and McGill University and a pioneer in research on the nervous system. He was also a member of the Royal Society of Canada, an Officer of the Order of Canada and an Officer of the Ordre national du Québec. He was a research professor in the Departments of Physiology and Medicine at the Université de Montréal. De Champlain died of a heart attack.

(See a Problem?)

Jacques de Champlain's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS. (1964) (414)
Circulating Catecholamine Levels in Human and Experimental Hypertension (1976) (393)
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. (1994) (296)
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. (1994) (260)
Ontogenesis of peripheral adrenergic neurons in the rat: pre- and postnatal observations. (1970) (253)
Influence of respiration on heart rate and blood pressure fluctuations. (1993) (249)
Oxidative Stress in Hypertension (2004) (208)
Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. (1977) (168)
Activation of neurohumoral systems in postinfarction left ventricular dysfunction. (1993) (166)
Regulation of Blood Pressure by Sympathetic Nerve Fibers and Adrenal Medulla in Normotensive and Hypertensive Rats (1972) (164)
Plasma norepinephrine response to exercise before and after training in humans. (1981) (159)
Correlation between the Response of the Heart to Sympathetic Stimulation and the Release of Endogenous Catecholamines into the Coronary Sinus of the Dog (1975) (158)
Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by &agr;-Lipoic Acid (2002) (157)
Antioxidative Properties of Acetylsalicylic Acid on Vascular Tissues From Normotensive and Spontaneously Hypertensive Rats (2002) (151)
Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. (2003) (144)
Relationship between Sodium Intake and Norepinephrine Storage during the Development of Experimental Hypertension (1968) (142)
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. (1967) (137)
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. (1998) (124)
Catecholamines in coronary sinus during exercise in man before and after training. (1977) (121)
Enhanced sensitivity of caudate neurones to microiontophoretic injections of dopamine in 6-hydroxydopamine treated cats. (1972) (120)
Interrelationships of sodium intake, hypertension, and norepinephrine storage in the rat. (1969) (119)
Turnover and synthesis of norepinephrine in experimental hypertension in rats. (1969) (118)
The sympathetic system in hypertension. (1977) (118)
Factors controlling renin in man. (1966) (117)
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. (1991) (110)
Catecholamines released from cerebral cortex in the cat; decrease during sensory stimulation (1976) (109)
Activation of neurohumoral systems following acute myocardial infarction. (1991) (108)
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. (2007) (106)
The effect of 2 sympatholytic medications--propranolol and clonidine--on sleep bruxism: experimental randomized controlled studies. (2006) (105)
Degeneration and Regrowth of Adrenergic Nerve Fibers in the Rat Peripheral Tissues after 6-Hydroxydopamine (1971) (104)
Plasma catecholamines in acute myocardial infarction. (1979) (104)
Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. (1998) (102)
Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats (2001) (100)
MEASUREMENT OF HUMAN ARTERIAL RENIN ACTIVITY IN SOME PHYSIOLOGICAL AND PATHOLOGICAL STATES. (1964) (98)
Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. (1982) (96)
Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system. (1972) (95)
DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. (1993) (93)
Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. (1987) (92)
Endocrine factors in congestive heart failure. (1968) (83)
Abnormal Storage of Norepinephrine in Experimental Hypertension in the Rat (1967) (83)
Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF. (1982) (77)
Persistence of caudate unitary responses to nigral stimulation after destruction and functional impairment of the striatal dopaminergic terminals. (1972) (76)
Acute and Chronic Cardiovascular Effects of 6‐Hydroxydopamine in Dogs (1972) (72)
QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. (1983) (70)
Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats (2003) (70)
Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine. (1971) (68)
Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. (2004) (67)
Altered ontogenesis of central noradrenergic neurons following neonatal treatment with 6-hydroxydopamine. (1972) (67)
Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats (2002) (64)
Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats (2004) (64)
NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells (2003) (63)
STUDIES ON THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS. (1964) (63)
Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II–Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats (2005) (61)
Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. (1998) (60)
The sympathetic system in hypertension. (1977) (59)
N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. (2003) (59)
Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats. (2004) (58)
Effect of the renin–angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients (2005) (57)
Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. (2005) (57)
6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves. (1971) (56)
Altered cardiorespiratory transfer in hypertension. (1994) (55)
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent (2001) (55)
[Interaction between the sympathetic and renin-angiotensin system]. (1998) (54)
The intracortical distribution of norepinephrine, dopamine and serotonin in the cerebral cortex of the cat (1979) (54)
Excitation and prolonged waking produced by catecholamines injected into the ventricular system of cats. (1971) (54)
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension (2002) (53)
Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. (2006) (53)
Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in Mice (2008) (52)
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. (2005) (51)
The postnatal development of noradrenaline uptake in the adrenergic nerves of different tissues from the rat. (1970) (50)
Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. (1997) (49)
Subcellular localization of monoamine oxidase in rat tissues. (1969) (47)
Pre- and postsynaptic adrenergic dysfunctions in hypertension. (1990) (46)
Effects of superoxide on signaling pathways in smooth muscle cells from rats. (1999) (46)
Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan. (2000) (45)
The development of sympathetic innervation and the functional state of the cardiovascular system in newborn dogs. (1975) (44)
Low Serum Ferroxidase I Activity Is Associated With Mortality in Heart Failure and Related to Both Peroxynitrite-Induced Cysteine Oxidation and Tyrosine Nitration of Ceruloplasmin (2014) (44)
Muscarinic inhibition of endogenous myocardial catecholamine liberation in the dog. (1978) (43)
Increased Monoamine Oxidase Activity during the Development of Cardiac Hypertrophy in the Rat (1968) (43)
The role of the sympathetic system in experimental and human hypertension. (1977) (41)
Exercise plasma catecholamines in dogs: role of adrenals and cardiac nerve endings. (1981) (41)
Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats. (2008) (40)
Circulating catecholamines and systolic time intervals in labile and sustained hypertension. (1978) (39)
Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. (1988) (39)
Effects of antihypertensive therapies on the sympathetic nervous system. (1999) (38)
Sodium and water excretion abnormalities in congestive heart failure. Determinant factors and clinical implications. (1986) (38)
Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit. (1991) (38)
Abnormal cardiovascular reactivity in borderline and mild essential hypertension. (1991) (37)
Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. (1990) (37)
Persistent effects of a marathon run on the pituitary-testicular axis (1986) (37)
The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance (2007) (37)
Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension. (1980) (36)
A reduction in the accumulation of H3-norepinephrine in experimental hypertension. (1966) (36)
Sympathetic indices during psychological and physical stimuli before and after training (1985) (35)
Circulating catecholamines and systolic time intervals in normotensive and hypertensive patients with and without left ventricular hypertrophy. (1978) (33)
Enhanced inhibition by melatonin of α‐adrenoceptor‐ induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from spontaneously hypertensive rats (1998) (33)
Sympathetic functions in NG‐nitro‐L‐arginine‐methylester‐induced hypertension: modulation by the renin‐angiotensin system (1998) (33)
Increased biosynthesis of cardiac norepinephrine after hypophysectomy. (1969) (33)
The sixth Stevenson Lecture. The contribution of the sympathetic nervous system to arterial hypertension. (1978) (32)
Cardiac catechol O-methyltransferase and monoamine oxidase activity in congestive heart failure. (1968) (32)
Participation of central noradrenergic neurons in experimental hypertension. (1977) (32)
Effects of Valsartan or Amlodipine Alone or in Combination on Plasma Catecholamine Levels at Rest and During Standing in Hypertensive Patients (2007) (32)
Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients. (2013) (31)
Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. (2006) (31)
Cardiovascular effects of Buthus martensii (Karsch) scorpion venom. (1994) (30)
Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. (2008) (29)
Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium. (1990) (29)
Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes (2005) (29)
Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine. (1971) (27)
Pre- and postsynaptic adrenergic dysfunctions in hypertension. (1990) (27)
Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. (1991) (27)
Modulation by beta-adrenoceptors and angiotensin II receptors of splanchnic nerve evoked catecholamine release from the adrenal medulla. (1991) (27)
Sympathoadrenal Mechanisms Underlying Cardiovascular Responses to Intrathecal Substance P in Conscious Rats (1990) (27)
Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease (2013) (26)
Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats. (1987) (25)
Myocardial dysfunction and norepinephrine release in the isolated rat heart injured by electrolysis-induced oxygen free radicals. (1991) (25)
Recommendations from the Consensus Conference on Hypertension in the Elderly. (1986) (25)
Diagnostic significance of humoral factors in renovascular hypertension (1966) (24)
Epinephrine release from the heart during left stellate ganglion stimulation in dogs. (1988) (24)
Attenuation of Autonomic Nervous System Functions in Hypertensive Patients at Rest and During Orthostatic Stimulation (2008) (23)
The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase. (2006) (23)
Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats. (1985) (22)
Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord. (1991) (22)
Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: a prospective long term study of 200 patients. (1990) (22)
Radioautographic visualization of central catecholamine neurons in newborn rat after intravenous administration of tritiated norepinephrine (1976) (22)
Catecholamine release and ventricular arrhythmias during coronary occlusion and reperfusion in the dog. (1985) (21)
Presynaptic effects of epinephrine on norepinephrine release from cardiac sympathetic nerves in dogs. (1993) (21)
Inhibitory effect of melatonin on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. (2004) (21)
Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo. (2006) (21)
Rong Wu , Daniel Lamontagne and Jacques de Champlain and Spontaneously Hypertensive Rats Antioxidative Properties of Acetylsalicylic Acid on Vascular Tissues From Normotensive (2002) (21)
Oxidative Stress by-Lipoic Acid (2002) (20)
Lack of correlation between age and circulating catecholamines in hypertensive patients. (1977) (20)
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance (2005) (20)
Regulation of Blood Pressure by Sympathetic Nerve Fibers and Adrenal Medulla in Normotensive and Hypertensive Rats (1972) (20)
The release of catecholamines from the adrenal medulla and its modulation by alpha 2-adrenoceptors in the anaesthetized dog. (1987) (19)
Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. (1985) (19)
Increased sympatho-adrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats. (1986) (19)
Altered coronary dilation in deoxycorticosterone acetate‐salt hypertension (2000) (19)
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension (2004) (19)
Skeletal muscle and cardiac changes with training in patients with angina pectoris. (1982) (18)
Blood pressure and plasma catecholamine responses to various challenges during exercise-recovery in man (2006) (18)
Acute and chronic effects of free radicals on α1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats (2005) (18)
Sympathetic abnormalities in human hypertension. (1981) (18)
FREE AND CONJUGATED CATECHOLAMINES IN PLASMA AND ERYTHROCYTES DURING EXERCISE AND FOLLOWING RECOVERY (1983) (17)
Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension (2003) (17)
Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats. (1996) (17)
Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension. (1983) (17)
Regulation of the endothelin-1 transmembrane signaling pathway: the potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure. (1993) (17)
Effects of sotalol, (-)-propranolol and prazosin on reperfusion-induced arrhythmias and increased cardiac norepinephrine release. (1986) (17)
Increased Plasma Catecholamines in Patients with Friedreich’s Ataxia (1982) (17)
Review of a mock research protocol in functional neuroimaging by Canadian research ethics boards (2006) (16)
Increased circulating plasma catecholamines and plasma renin activity in dogs after chemical sympathectomy with 6-hydroxydopamine. (1977) (16)
The postsynaptic effect of amphetamine on striatal dopamine-sensitive neurones (1974) (16)
Regulation of Norepinephrine Release from Cardiac Sympathetic Fibers in the Dog by Presynaptic a- and /?-Receptors (2005) (16)
Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure. (1993) (16)
Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension. (1993) (16)
Effects of trandolapril on the sympathetic tone and reactivity in systemic hypertension. (1994) (16)
Vasovagal syncope: management with atrioventricular sequential pacing and beta-blockade. (1989) (16)
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. (2005) (16)
Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. (2005) (15)
Abnormal regulation of cytosolic free calcium in vascular endothelial cells from spontaneously hypertensive rats (1995) (15)
Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo. (1997) (15)
Role of sympathetic fibers and of adrenal medulla in the maintenance of cardiovascular homeostatis in normotensive and hypertensive animals (1973) (14)
Ontogenesis of sympathetic fibers after neonatal 6-hydroxydopamine treatment in the rat. (1974) (14)
Therapeutic potential of angiotensin II receptor antagonists (2001) (14)
Sequential changes in catecholamine plasma levels during isotonic volume expansion in dogs. (1978) (14)
Peripheral neurogenic mechanisms in deoxycorticosterone acetate--salt hypertension in the rat. (1989) (14)
Superoxide anion-induced formation of inositol phosphates involves tyrosine kinase activation in smooth muscle cells from rat mesenteric artery. (1999) (14)
The sympatho-adrenal tone and reactivity in human hypertension. (1989) (14)
Noradrenaline liberation from the dog heart in vivo. (1973) (14)
Comparative effects of 6-hydroxy-dopamine and of reserpine on quabain toxicity in the rat. (1973) (13)
Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats (2005) (13)
Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension. (2011) (13)
Do most antihypertensive agents have a sympatholytic action? (2001) (12)
Increased monoamine oxidase activity in isoproterenol-stimulated submaxillary glands. (1968) (12)
Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart. (1994) (12)
A Survey of Electrophysiology and Pharmacology of Neostriatal Input-Output Relations (1979) (12)
Corelease of neuropeptide Y like immunoreactivity with catecholamines from the adrenal gland during splanchnic nerve stimulation in anesthetized dogs. (1990) (12)
Cardiovascular responses to intrathecal neuropeptide γ in conscious rats: receptor characterization and mechanism of action (1996) (12)
Potentiated endothelin-1-induced phosphoinositide hydrolysis in atria and mesenteric artery of DOCA-salt hypertensive rats. (1989) (12)
Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats. (1986) (12)
Protective Effects of Aspirin from Cardiac Hypertrophy and Oxidative Stress in Cardiomyopathic Hamsters (2012) (12)
Selective activation of the adrenal medulla during acute bilateral carotid occlusion and its modulation by alpha-adrenergic receptors in the rat. (1983) (12)
Autonomic Dysfunctions in Human Hypertension (1981) (12)
Free and conjugated catecholamines in plasma and erythrocytes of normotensive and labile hypertensive subjects during exercise and recovery. (1985) (11)
Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme? (1994) (11)
Correlation between neural release of VIP and adrenomedullary catecholamine secretion in vivo. (1995) (11)
Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats (2003) (10)
Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action (1994) (10)
Reduction of tissue noradrenaline content in the isolated perfused rat heart during ischemia: importance of monoamine oxidation. (1991) (10)
Does QTc interval predict the response to beta-blockers and calcium channel blockers in hypertensives? (2003) (10)
Fasting in obese females. II. Plasma renin activity and urinary aldosterone. (1968) (10)
Involvement of the cyclic GMP pathway in the superoxide‐induced IP3 formation in vascular smooth muscle cells (2000) (10)
Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog (2004) (10)
Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats. (1989) (10)
Occlusion time dependency of regional noradrenaline release and cardiac arrhythmias during reperfusion of acutely ischaemic heart in the dog in vivo. (1990) (10)
Altered protein kinase C regulation of phosphoinositide-coupled receptors in deoxycorticosterone acetate-salt hypertensive rats. (1994) (10)
Free and conjugated catecholamines in plasma and red blood cells of normotensive and hypertensive patients. (1984) (10)
Original contributionAlteration of prejunctional α2-adrenergic α2-utoinhibition in DOCA-salt hypertension (1995) (10)
Constitutive nonexocytotic norepinephrine release in sympathetic curves of in situ canine heart. (1994) (9)
Sympatho-adrenal and cardiovascular responses during hand-grip in human hypertension. (1989) (9)
Is there a role for reactive oxygen species in arterial medial elastocalcinosis? (2007) (9)
Atrial natriuretic factor: a possible link between left atrium, plasma volume, adrenergic control and renin-aldosterone in the mitral valve prolapse syndrome. (1986) (9)
Dysfunction of the / 3-and a-Adrenergic Systems in a Model of Congestive Heart Failure The Pacing-Overdrive Dog (2005) (9)
Effects of Buthus martensii Karsch scorpion venom on the release of noradrenaline from in vitro and in vivo rat preparations. (1994) (9)
Effect of Chronic Inhibition of Nitric Oxide on Hypertension, Insulin Resistance, and Cardiovascular Remodeling in Glucose-fed Rats (2009) (9)
Selective activation of neurohormonal systems in post-infarction left ventricular dysfunction (1991) (9)
Effects of 6‐Hydroxydopamine on the Canine Sinus Node (1971) (9)
Blood and plasma volume changes in dogs after sympathectomy with 6-hydroxydopamine. (1977) (8)
Do most antihypertensive agents have a sympatholytic action? (2001) (8)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial of Four Doses of Tasosartan in Patients With Essential Hypertension (1998) (8)
Reflexly induced inhibition of catecholamine release through a peripheral muscarinic mechanism. (1980) (8)
MODULATION OF ADRENAL CATECHOLAMINE RELEASE BY DA2 DOPAMINE RECEPTORS IN THE ANAESTHETIZED DOG (1988) (8)
Receptor and mechanism that mediate endothelin- and big endothelin-1-induced phosphoinositide hydrolysis in the rat spinal cord. (1996) (8)
Presynaptic inhibitory effects of sotalol, propranolol, and acebutolol on noradrenaline release upon cardiac sympathetic nerve stimulation in anesthetized dogs. (1986) (8)
Effect of 6-hydroxydopamine on diet-induced hyperlipidemia and atherosclerosis in the rat. (1976) (8)
The activity of the renin-angiotensin-aldosterone system in hypertensive and hydropic diseases (1966) (8)
Evidence for the participation of sodium-sensitive pontine catecholaminergic neurons in the maintenance of DOCA-sodium hypertension in rats. (1980) (8)
EFFECT OF SOTALOL AGAINST REPERFUSION‐INDUCED ARRHYTHMIAS IN SPRAGUE‐DAWLEY AND WISTAR RATS (1989) (8)
Effects of nifedipine and Bay K 8644 on stimulation-induced adrenal catecholamine secretion in the dog. (1993) (8)
Acute and chronic effects of free radicals on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. (2005) (7)
Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension. (1992) (7)
Prolonged qt interval and autonomic imbalance: A clue for the prevention of sudden death in mitral valve prolapse (1981) (7)
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension. (1998) (7)
Plasma-sulfate-conjugated catecholamines during anesthesia. (1983) (7)
Altered calcium homeostasis in tail artery endothelial cells from spontaneously hypertensive rats. (1995) (7)
In vivo interactions between prejunctional α2- and β2-adrenoceptors at the level of the adrenal medulla (1988) (7)
Effects of acute and chronic administration of sotalol on the blood pressure and the sympathoadrenal activity of anesthetized deoxycorticosterone acetate-salt hypertensive rats. (1986) (6)
Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs. (1990) (6)
[THE ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN THE REGULATION OF SODIUM METABOLISM IN MAN]. (1964) (6)
Use of Circulating Catecholamines for the Detection of Autonomic Abnormalities in Human Hypertension (1981) (6)
Liberation of cyclic AMP and catecholamine from the heart during left stellate stimulation in the anesthetized dog. (1981) (6)
Cardiovascular reactivity in the dog after chemical sympathectomy with 6-hydroxydopamine. (1974) (6)
Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo? (2011) (6)
The vasorelaxant effect of deuterium oxide is secondary to calcium-induced liberation of nitric oxide by endothelial cells (1993) (6)
Reflex adrenal medullary secretion during coronary occlusion mediated by cardiac receptors with afferent vagal fibres in the rat (1997) (6)
Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. (1995) (6)
Plasma catecholamines and response to exercise in 6-hydroxydopamine-treated dogs. (1982) (6)
Do angiotensin II antagonists provide benefits beyond blood pressure reduction? (2005) (5)
Effect of changes in myocardial epinephrine stores on plasma norepinephrine gradient across the dog heart. (1994) (5)
Effects of exercise training on plasma catecholamines and blood pressure in labile hypertensive subjects (2004) (5)
ONTOGENESIS OF CENTRAL AND PERIPHERAL ADRENERGIC NEURONS IN THE RAT FOLLOWING NEONATAL TREATMENT WITH 6-HYDROXYDOPAMINE (1974) (5)
Effects of yohimbine and desipramine on cardiac noradrenaline release and ventricular arrhythmias during acute coronary artery occlusion and reperfusion in anesthetized dogs. (1987) (5)
Coronary sinus norepinephrine concentrations during ventricular tachycardia induced by left stellate ganglion stimulation in dogs. (1988) (5)
Effects of chronic dietary lithium on phosphatidylinositol pathway in heart and arteries of DOCA-salt hypertensive rats. (1988) (4)
Red blood cell catecholamine levels in normotensive and DOCA-salt hypertensive rats. (1987) (4)
Nifedipine inhibits adrenal but not circulating catecholamine response to nicotinic stimulation in dogs. (1994) (4)
Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity. (1990) (4)
O-53: Hypotensive effect of genistein in angiotensin-treated hypertensive rats; implication of the ERK-MAPK pathway and the superoxyde anion radical (2001) (3)
Abnormalities in the regulation of sympathetic activity in human hypertension. (1987) (3)
In vivo modulation by alpha 2-adrenoceptors of adrenal catecholamine release in the anaesthetized dog. (1988) (3)
Effects of d,l-propranolol, d-propranolol, l-propranolol, and sotalol on myocardial contractility and coronary resistance. (1973) (3)
Absence of prejunctional sympathetic effect of amiodarone in hearts of open-chest anesthetized dogs. (1990) (3)
Correlation between changes in endogenous catecholamine release from the heart and various physiological responses in anesthetized dogs. (1976) (3)
[Neurogenic factors in human hypertension]. (1977) (3)
Sympathetic functions in N: modulation by the renin-angiotensin systemg: modulation by the renin-angiotensin system-nitro-l-arginine-methylester-induced hypertension: modulation by the renin-angiotensin system (1998) (3)
Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat (2004) (3)
25 Effect of losartan on endothelium‐dependent relaxation in spontaneously hypertensive rats (1994) (3)
Role of sympathetic fibres and of adrenal medulla in the maintenance of cardio-vascular homeostasis in normotensive and hypertensive rats (1974) (3)
P-317: Role of oxidative stress in the development of hypertension in SHR (2001) (3)
Do angiotensin II antagonists provide benefits beyond blood pressure reduction? (2005) (3)
[Role of endothelin in the hypertrophic remodeling of small arteries induced by exogenous norepinephrine]. (1999) (2)
Plasma catecholamines, heart rate, and cardiac sympathetic activity in exercising dogs. (1982) (2)
In vivo interactions between prejunctional alpha 2- and beta 2-adrenoceptors at the level of the adrenal medulla. (1988) (2)
Plasma Catecholamines in Normotensive Children and in Children with Essential Hypertension (1981) (2)
Angiotensin-Endothelin Interactions (2004) (2)
Enhanced presynaptic beta 2-adrenergic facilitatory mechanism in conscious deoxycorticosterone acetate-salt hypertensive rats. (1991) (2)
Effect of increases in myocardial epinephrine content on epinephrine release from the dog heart. (1993) (2)
Plasma Catecholamines Following Low and High Doses of Ouabain in Anesthetized Dogs With or Without Cervical Vagotomy (1980) (2)
Gender‐related differences in advanced glycation endproducts and oxidative stress markers in rats (2006) (2)
Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogs. (1992) (2)
[PHYSIOLOGICAL RELATIONSHIP BETWEEN THE RENIN-ANGIOTENSIN SYSTEM AND ALDOSTERONE]. (1965) (2)
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group. (1998) (2)
Narcolepsy and idiopathic hypersomnia (1982) (2)
INTERACTIONS BETWEEN BIOGENIC AMINES AND ACETYLCHOLINE IN THE CEREBRAL CORTEX (1979) (1)
The role of the sympathetic system in the maintenance of human hypertension. (1978) (1)
Cardiac reflex activity in chemically sympathectomized dogs in response to hypotension or hypertension. (1977) (1)
Plasma catecholamines and local modifications of sympathetic nervous activity. (1984) (1)
Catecholamine-ouabain interaction on the isolated perfused rat heart. (1975) (1)
948-49 Prognostic Importance of the Oxidation Products of Catecholamines (Adrenochromes) in Patients with Heart Failure (1995) (1)
1012-129 Dual angiotensin-II suppression with angiotensin-converting enzyme inhibitor and irbesartan improves submaximal exercise time without changes in exercise-induced neurohumoral response in patients with congestive heart failure (2004) (1)
Role of the renin-angiotensin system on the central and peripheral autonomic nervous system (2001) (1)
Report on the Discussion of the Fourth Session (1972) (1)
Kinin B1 Receptor as a Therapeutic Target in the Treatment of Diabetes (2008) (1)
A direct “post-synaptic” and “dopamine-like” effect of amphetamine on caudate neurones (1973) (1)
[The physiological relationship between the renin-angiotensin system and aldosterone]. (1965) (1)
Sympathetic Nervous System and Deoxycorticosterone‐Saline Hypertension (1973) (0)
THE SIGNIFICANCE OF ASSESSING CIRCULATING CATECHOLAMINES IN THE EVALUATION AND TREATMENT OF HYPERTENSIVE PATIENTS (1979) (0)
1083 Study on different gender of rats in glucose-L-NAME induced hypertension and insulin resistance as well as in the response to aspirin (2012) (0)
Effects of renin-angiotensin blockade on the modulation of β-adrenergic receptors in the SHR (1997) (0)
New Procedures for Measurement of Human Plasma Angiotensin and Renin Activity Levels (2007) (0)
The sixth Stevenson Lecture. The contribution of the sympathetic nervous system to arterial hypertension. (1978) (0)
HEART RATE VARIABILITY IN HYPERTENSIVE PATIENTS TREATED WITH AMLODIPINE, RAMIPRIL ORTELMISARTAN: OP 080 (2004) (0)
[Mitral valve prolapse syndrome. Arrhythmia, abnormalities of the ventricular contraction and dysfunction of the autonomic nervous system]. (1980) (0)
[Possible role of catecholamines in the inotropic effect of ouabain on the isolated perfused rat heart]. (1973) (0)
Chronic Inhibition of Nitric Oxide Synthase Worsen Hypertension and Insulin Resistance, but not Cardiovascular Remodeling, in Glucose-Fed Rats. (2008) (0)
562: BLOOD PRESSURE AND PLASMA CA AT REST AND IN RESPONSE TO VARIOUS CHALLENGES DURING RECOVERY FROM EXERCISE (1987) (0)
Therapeutic potential of angiotensin II receptor (2001) (0)
EFFECTS OF TELMISARTAN, RAMIPRIL AND AMLODIPINE ON ORCADIAN BLOOD PRESSURE, HEART RATE, NOREPINEPHRINE, RENIN AND ALDOSTERONE CYCLES IN ESSENTIAL HYPERTENSIVE PATIENTS: OP 029 (2004) (0)
Role of endothelin receptor antagonist in preventing small artery hypertrophy induced by exogenous administration of noradrenaline (1999) (0)
Effect of high glucose intake and insulin resistance on oxidative stress and arterial pressure in the rat (2001) (0)
[Recommendations of the consensus conference on hypertension in aged patients]. (1987) (0)
ROLE OF CYCLOOXYGENASE-2 PATHWAY IN ANTI-OXIDATIVE EFFECT OF ASPIRIN AND IN ANGIOTENSIN II-INDUCED OXIDATIVE STRESS: PP.29.160 (2010) (0)
EFFECTS OF GLUCOSE AND INSULIN ON THE DEVELOPMENT OF THE OXIDATIVE STRESS AND HYPERTENSION IN MODELS OF TYPE 1 AND TYPE 2 DIABETES: OP 013 (2004) (0)
Methods of Study for Biogenic Amines (1975) (0)
Effects of superoxide anion on inositol phosphates production and on the aortic reactivity to α1-adrenergic receptors in SHR (1997) (0)
152 Impairment of endothelium-dependent relaxation in the mesenteric arteries of deoxycorticosterone-salt hypertensive rats (1993) (0)
Characterization of the cardiovascular and sympathoadrenal responses to intrathecally administered neuropeptide K in the conscious rat (1992) (0)
INFLUENCE OF ORCADIAN RHYTHMS, BODY POSTURE AND ANTIHYPERTENSIVE DRUGS ON THE ALDOSTERONE-TO-RENIN RATIO IN PATIENT WITH ESSENTIAL HYPERTENSION: P 764 (2004) (0)
P-439: Comparative effects of amlodipine, ramipril and telmisartan on 24-hour ambulatory blood pressure in mild to moderate hypertensive patients (2003) (0)
THE ROLE OF ENDOTHELIN IN THE LONG TERM STIMULATION OF NAD(P)H OXIDASE BY ANGIOTENSIN II IN VASCULAR SMOOTH MUSCLE CELLS: P 674 (2004) (0)
271 – CATECHOLAMINE LIBERATION FOLLOWING INTRAVEINOUS ADMINISTRATION OF OUABAIN IN THE DOG (1977) (0)
Chronic Drug Treatment of Essential Hypertension (1995) (0)
Hemodynamic responses and neurohormonal activation in “responders” vs. “non-responders” to triple neurohormonal blockade in congestive heart failure (2004) (0)
EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) ON ANGIOTENSIN II-INDUCED OXIDATIVE STRESS, HYPERTENSION AND CARDIAC HYPERTROPHY IN RATS: P 279 (2004) (0)
[CORRELATION BETWEEN THE ASSESSMENT OF THE ACTIVITY OF RENIN IN THE PLASMA AND THE METABOLIC STATE OF SODIUM IN THE NORMAL MAN]. (1964) (0)
P-200: Effects of telmisartan, ramipril and amlodipine on circadian blood pressure, heart rate and norepinephrine cycles in essential hypertensive patients (2003) (0)
The use of angiotensin-converting enzyme inhibitors in congestive heart failure (1989) (0)
Sympathetic Nervous System and Deoxycorticosterone-Saline Hypertension (1973) (0)
[Role of cyclo-oxygenases in the effects of angiotensin II]. (2006) (0)
A084: Spectral analysis of blood pressure variability before and after exercise during angiotensin antagonism (2000) (0)
The effects of physical training in labile hypertension (1982) (0)
20 Modification in the sensitivity of beta‐adrenergic signalling pathway in a rat model of myocardial infarct (1994) (0)
TRAINING AND LABILE HYPERTENSION: BLOOD PRESSURE AND PLASMA CATECHOLAMINES (1982) (0)
[Hypertension and the sympathetic nervous system: research to pursue. Interview by Robert Henry]. (1990) (0)
The clinical evaluation of hypertension. (1985) (0)
Insulin, AGE and hypertension (2005) (0)
INHIBITION OF NUCLEAR FACTOR-KAPPA B AND NAD(P)H OXIDASE SUBUNIT P47 PHOX EXPRESSION ARE ASSOCIATED WITH THE EFFECT OF ASPIRIN AGAINST ANGIOTENSIN II-INDUCED OXIDATIVE STRESS AND HYPERTENSION: P1.150 (2004) (0)
Clinical, electrocardiogram, and echocardiographic characteristics in hypertensive men and women with and without paroxysmal atrial fibrillation (2011) (0)
Evidence for the participation of sodium-sensitive pontine catecholaminergic neurons in the maintenance of DOCA-sodium hypertension in rats. (1980) (0)
[Role of the sympathetic nervous system in arterial hypertension]. (1985) (0)
Risk factor modulating with new generation vasodilating β-blockers: Introduction (1991) (0)
The clinical evaluation of hypertension. (1985) (0)
Insulin, AGE and hypertension. Authors' reply (2005) (0)
[Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)]. (1965) (0)
Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. (1998) (0)
C005 Serotoninergic 5-HT2B receptor blockade prevents superoxide anion mediated cardiac hypertrophy induced by angiotensin II (2009) (0)

This paper list is powered by the following services:

Other Resources About Jacques de Champlain

en.wikipedia.org

What Schools Are Affiliated With Jacques de Champlain?

Jacques de Champlain is affiliated with the following schools:

Jacques de Champlain's Academic­Influence.com Rankings